LncRNA GACAT3: A Promising Biomarker and Therapeutic Target in Human Cancers

被引:7
|
作者
Yuan, Xin [1 ]
Dong, Zihui [1 ,2 ]
Shen, Shen [1 ,2 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Infect Dis, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Affifiliated Hosp 1, Gene Hosp Henan Prov, Precis Med Ctr, Zhengzhou, Peoples R China
关键词
lncRNA; cancer; biomarker; GACAT3; molecular mechanisms; LONG NONCODING RNA; GASTRIC-CANCER; BREAST-CANCER; LUNG-CANCER; CELL-PROLIFERATION; PROMOTES; INVASION; EPIDEMIOLOGY; MIGRATION; LNCRNA-GACAT3;
D O I
10.3389/fcell.2022.785030
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Long non-coding RNAs (lncRNAs) are a class of functional RNA molecules that do not encode proteins and are composed of more than 200 nucleotides. LncRNAs play important roles in epigenetic and gene expression regulation. The oncogenic lncRNA GACAT3 was recently discovered to be dysregulated in many tumors. Aberrant expression of GACAT3 contributes to clinical characteristics and regulates multiple oncogenic processes. The association of GACAT3 with a variety of tumors makes it a promising biomarker for diagnosis, prognosis, and targeted therapy. In this review, we integrate the current understanding of the pathological features, biological functions, and molecular mechanisms of GACAT3 in cancer. Additionally, we provide insight into the utility of GACAT3 as an effective diagnostic and prognostic marker for specific tumors, which offers novel opportunities for targeted therapeutic intervention.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
    Xiao, Yuhang
    Xiao, Ta
    Ou, Wei
    Wu, Zhining
    Wu, Jie
    Tang, Jinming
    Tian, Bo
    Zhou, Yong
    Su, Min
    Wang, Wenxiang
    BIOMARKER RESEARCH, 2020, 8 (01)
  • [2] LncRNA HOXA10-AS as a novel biomarker and therapeutic target in human cancers
    Hu, Xin
    Wang, Yong
    Zhang, Sijia
    Gu, Xiaosi
    Zhang, Xiaoyu
    Li, Lianlian
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2025, 11
  • [3] LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
    Yuhang Xiao
    Ta Xiao
    Wei Ou
    Zhining Wu
    Jie Wu
    Jinming Tang
    Bo Tian
    Yong Zhou
    Min Su
    Wenxiang Wang
    Biomarker Research, 8
  • [4] The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?
    Zhang, Naibin
    Bian, Qiang
    Gao, Yankun
    Wang, Qianqian
    Shi, Ying
    Li, Xiangling
    Ma, Xiaolei
    Chen, Huiyuan
    Zhao, Zhankui
    Yu, Honglian
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [5] The Role of Fascin-1 in Human Urologic Cancers: A Promising Biomarker or Therapeutic Target?
    Zhang, Naibin
    Bian, Qiang
    Gao, Yankun
    Wang, Qianqian
    Shi, Ying
    Li, Xiangling
    Ma, Xiaolei
    Chen, Huiyuan
    Zhao, Zhankui
    Yu, Honglian
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
  • [6] LncRNA GACAT3 promotes gastric cancer progression by negatively regulating miR-497 expression
    Feng, Li
    Zhu, Yonggang
    Zhang, Yunxin
    Rao, Min
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 97 : 136 - 142
  • [7] lncRNA ZEB2-AS1: A promising biomarker in human cancers
    Mahboobeh, Zarei
    Pegah, Mousavi
    Fatemeh, Sadri
    Elham, Karimi
    Hanieh, Azari
    Milad, Rafat
    Mohammad, Shekari
    IUBMB LIFE, 2020, 72 (09) : 1891 - 1899
  • [8] LncRNA DARS-AS1 in human cancers: A comprehensive review of its potency as a biomarker and therapeutic target
    Dang, Qiucai
    GENE, 2024, 923
  • [9] NALCN is a potential biomarker and therapeutic target in human cancers
    He, Jian
    Xu, Jie
    Chang, Zhiwei
    Yan, Jiaqin
    Zhang, Limin
    Qin, Yanru
    FRONTIERS IN GENETICS, 2023, 14
  • [10] Circular RNA: a novel biomarker and therapeutic target for human cancers
    Lei, Bo
    Tian, Zhiqiang
    Fan, Weiping
    Ni, Bing
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2019, 16 (02): : 292 - 301